Giacomo Nuvola
Via Albertoni-15
Bologna, 40138, Italy
Bologna, 40138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
The future of immunotherapy in advanced renal cell carcinoma: beyond PD-1/PD-L1 inhibitors.
Journal: Immunotherapy
Published: September 18, 2023
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer.
Journal: Expert review of anticancer therapy
Published: May 15, 2023
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma.
Journal: Expert opinion on drug safety
Published: April 13, 2023
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: July 11, 2022
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.
Journal: Pathology, research and practice
Published: May 26, 2022
Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy.
Journal: Cancer management and research
Published: March 24, 2022
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw.
Journal: Current oncology (Toronto, Ont.)
Published: January 31, 2022
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?
Journal: Cancers
Published: January 03, 2022
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT.
Journal: International journal of molecular sciences
Published: November 17, 2021
Last Updated: 09/26/2026